(Q34207012)

31 July 2017

1 reference

title

An update on glucocorticoid-induced osteoporosis. (English)

1 reference

glucocorticoid-induced osteoporosis

31 July 2017

0 references

1 reference

N E Lane

1

1 reference

31 July 2017

1 February 2001

1 reference

Rheumatic Diseases Clinics of North America

31 July 2017

1 reference

31 July 2017

27

1 reference

31 July 2017

1

1 reference

31 July 2017

235-253

1 reference

Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The effect of glucocorticoids on bone mass in rheumatoid arthritis patients. Influence of menopausal state

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Steroid myopathy in connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The role of calcitonin in the prevention of osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

25 years of salmon calcitonin: from synthesis to therapeutic use

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Differential effects of continuous and transient treatment with parathyroid hormone related peptide (PTHrp) on bone collagen synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Glucocorticoid-induced inhibition of osteoblastic bone formation in ewes: a biochemical and histomorphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Hormonal status in normal, osteoporotic and corticosteroid-treated postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Steroid-induced osteoporosis in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The influence of prednisone on the muscle morphology and muscle enzymes in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Mean wall thickness and formation periods of trabecular bone packets in corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effects of 1,25-dihydroxycholecalciferol on intestinal calcium transport in cortisone-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle x-ray-scattering study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effects of chronic prednisolone treatment on bone resorption and bone composition in intact and ovariectomized rats and in ovariectomized rats receiving beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Corticosteroid-induced osteoporosis: effects of a treatment with slow-release sodium fluoride

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

In corticosteroid-treated respiratory diseases, monofluorophosphate increases lumbar bone density: a double-masked randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Altered mineral metabolism in glucocorticoid-induced osteopenia. Effect of 25-hydroxyvitamin D administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Remarkable improvement of osteopenia after cure of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Glucocorticoid inhibition of FSH-induced estrogen production in cultured rat granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Corticosteroid and bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Rapid loss of vertebral mineral density after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effect of cortisone treatment on the active transport of calcium by the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Decreased Clearance of Prednisolone, a Factor in the Development of Corticosteroid Side Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Differential effects of glucocorticoids on cortical appendicular and cortical vertebral bone mineral content

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The science and therapy of glucocorticoid-induced bone loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Rheumatoid arthritis and bone mineral density in elderly women. The Study of Osteoporotic Fractures Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effect of sodium fluoride on the prevention of corticosteroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Is addition of sodium fluoride to cyclical etidronate beneficial in the treatment of corticosteroid induced osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone densitometry: clinical considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone loss after glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone mineral loss, bone histomorphometry and vitamin D metabolism in patients with rheumatoid arthritis on long-term glucocorticoid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Reversible gonadotropin Deficiency in Male Cushing's Dusease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Analgesic effect of Salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Reduction of serum testosterone levels during chronic glucocorticoid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

New developments in the pathogenesis and treatment of steroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effect of salcatonin given intranasally on early postmenopausal bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Recovery from steroid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

PTH: a future role in the management of osteoporosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

The roles of calcium and vitamin D in the prevention of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Calcium supplements in the prevention of steroid-induced osteoporosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Prevention of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Corticosteroid-induced osteopenia and vitamin D metabolism. Effect of vitamin D2, calcium phosphate and sodium fluoride administration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Salmon calcitonin in the therapy of corticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Bisphosphonates: mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Inhibition of Luteinizing Hormone Secretion Induced by Synthetic LRH by Long-term Treatment with Glucocorticoids in Human Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Corticosteroid effects on proximal femur bone loss

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Determinants of axial bone loss in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Osteoporosis after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Risk of vertebral fracture in women with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Not all postmenopausal women on chronic steroid and estrogen treatment are osteoporotic: predictors of bone mineral density

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Use of oral corticosteroids and risk of fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Treatment of osteoporosis with bisphosphonates

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970196-4

7 January 2021

10.1016/S0889-857X(05)70196-4

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11285998